Aim Formulations Exims Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 03-01-2025
- Paid Up Capital ₹ 0.10 M
as on 03-01-2025
- Company Age 7 Year, 9 Months
- Last Filing with ROC 31 Mar 2020
- Revenue -86.76%
(FY 2019)
- Profit -97.46%
(FY 2019)
- Ebitda -74.95%
(FY 2019)
- Net Worth 0.57%
(FY 2019)
- Total Assets -21.50%
(FY 2019)
About Aim Formulations Exims
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Satyavathi Chandrabatla and Naga Chandrabhotla serve as directors at the Company.
- CIN/LLPIN
U24304AP2017PTC105543
- Company No.
105543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2017
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aim Formulations Exims?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyavathi Chandrabatla  | Director | 29-Mar-2017 | Current |
| Naga Chandrabhotla | Additional Director | 24-Nov-2021 | Current |
Financial Performance of Aim Formulations Exims.
Aim Formulations Exims Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 86.76% decrease. The company also saw a substantial fall in profitability, with a 97.46% decrease in profit. The company's net worth moved up by a moderate rise of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aim Formulations Exims?
In 2020, Aim Formulations Exims had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Devi Chitranshi Pharma Private LimitedInactive For E-Filing 11 months 6 daysNaga Chandrabhotla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aim Formulations Exims?
Unlock and access historical data on people associated with Aim Formulations Exims, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aim Formulations Exims, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aim Formulations Exims's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
